168 related articles for article (PubMed ID: 23849148)
1. Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators.
Mi X; Hammill BG; Curtis LH; Greiner MA; Setoguchi S
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S138-44. PubMed ID: 23849148
[TBL] [Abstract][Full Text] [Related]
2. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patients.
Weberpals J; Jansen L; Silversmit G; Verbeeck J; van der Geest L; Vissers PA; Zadnik V; Brenner H
Clin Epidemiol; 2018; 10():1109-1125. PubMed ID: 30214315
[TBL] [Abstract][Full Text] [Related]
4. Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.
Mi X; Hammill BG; Curtis LH; Lai EC; Setoguchi S
Stat Med; 2016 Nov; 35(26):4824-4836. PubMed ID: 27350312
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
8. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure.
Setoguchi S; Warner Stevenson L; Stewart GC; Bhatt DL; Epstein AE; Desai M; Williams LA; Chen CY
BMJ; 2014 May; 348():g2866. PubMed ID: 24812112
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention implantable cardioverter-defibrillators and survival in older women.
Zeitler EP; Hellkamp AS; Fonarow GC; Hammill SC; Curtis LH; Hernandez AF; Al-Khalidi HR; Curtis JP; Heidenreich PA; Anstrom KJ; Peterson ED; Mark DB; Hammill BG; Sanders GD; Al-Khatib SM
JACC Heart Fail; 2015 Feb; 3(2):159-67. PubMed ID: 25543969
[TBL] [Abstract][Full Text] [Related]
11. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure.
Hernandez AF; Fonarow GC; Hammill BG; Al-Khatib SM; Yancy CW; O'Connor CM; Schulman KA; Peterson ED; Curtis LH
Circ Heart Fail; 2010 Jan; 3(1):7-13. PubMed ID: 20009044
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Cardiac Resynchronization Therapy Defibrillators Versus Standard Implantable Defibrillators in Medicare Patients.
Zusterzeel R; Caños DA; Sanders WE; Silverman H; MaCurdy TE; Worrall CM; Kelman J; Marinac-Dabic D; Strauss DG
Am J Cardiol; 2015 Jul; 116(1):79-84. PubMed ID: 25933736
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest.
Chan PS; Krumholz HM; Spertus JA; Curtis LH; Li Y; Hammill BG; Nallamothu BK;
Am Heart J; 2015 Jun; 169(6):870-878.e1. PubMed ID: 26027626
[TBL] [Abstract][Full Text] [Related]
16. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.
Prutkin JM; Reynolds MR; Bao H; Curtis JP; Al-Khatib SM; Aggarwal S; Uslan DZ
Circulation; 2014 Sep; 130(13):1037-43. PubMed ID: 25081281
[TBL] [Abstract][Full Text] [Related]
17. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
[TBL] [Abstract][Full Text] [Related]
19. Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization.
Al-Chekakie MO; Bao H; Jones PW; Stein KM; Marzec L; Varosy PD; Masoudi FA; Curtis JP; Akar JG
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506978
[TBL] [Abstract][Full Text] [Related]
20. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
